US ‘Red Tape’ Bill Again Targets Biosimilar Interchangeability – Will It Succeed This Time?

AAM And Biosimilars Council Support Making All Biosimilars Interchangeable

 
• By Dave Wallace
  
The bill has been mooted multiple times in the past (Shutterstock)

More from Biosimilars

More from Policy & Regulation